WHO expects decisions on Pfizer, Moderna, AstraZeneca vaccines in weeks
GENEVA (Reuters) - The World Health Organization expects to make decisions on whether to give emergency use approval to COVID-19 vaccines from Pfizer, Moderna and AstraZeneca in coming weeks, its chief scientist said on Friday. Soumya Swaminathan said the global health body could decide on Pfizer's vaccine candidate in the next 'couple of weeks', and later said it could also review Moderna's and AstraZeneca's in a few weeks.
GENEVA (Reuters) - The World Health Organization expects to make decisions on whether to give emergency use approval to COVID-19 vaccines from Pfizer, Moderna and AstraZeneca in coming weeks, its chief scientist said on Friday.
Soumya Swaminathan said the global health body could decide on Pfizer's vaccine candidate in the next "couple of weeks", and later said it could also review Moderna's and AstraZeneca's in a few weeks.
WHO approval could allow a vaccine to be deployed in some countries where national medical regulators have not yet been able to evaluate it. Swaminathan said at least 10 companies had expressed an interest or submitted a request for emergency approval for vaccine candidates.
WHO Director-General Tedros Adhanom Ghebreyesus said nearly a billion doses of vaccines had been secured for the COVAX programme to provide shots for poor- and middle-income countries, with 189 countries participating.
But several WHO officials noted that it would still take time to manufacture enough doses of vaccines to meet demand. Swaminathan said the supply was likely to be limited for the first half of 2021.
(Reporting by Stephanie Nebehay, Emma Farge and Peter Graff; Writing by Peter Graff; Editing by Catherine Evans and Andrew Heavens)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
DAKAR (Reuters) - More than 20 people, including children, were killed in an airstrike during a wedding ceremony in central Mali on Sunday, a health worker with knowledge of the attack told Reuters. (Reporting By Edward McAllister; Editing by Aaron Ross)
By Estelle Shirbon and Natalie Thomas LONDON (Reuters) - Britain began its third COVID-19 lockdown on Tuesday with the government calling for one last major national effort to defeat the spread of a virus that has infected an estimated one in 50 citizens before mass vaccinations turn the tide. Finance minister Rishi Sunak announced a new package of business grants worth 4.6 billion pounds ($6.2 billion) to help keep people in jobs and firms afloat until measures are relaxed gradually, at the earliest from mid-February but likely later
By Dominique Vidalon and Sudip Kar-Gupta PARIS (Reuters) - France is stepping up its COVID-19 vaccine rollout by widening the first target group to include more health workers and simplifying a cumbersome process to deliver shots more quickly, Health Minister Olivier Veran said on Tuesday. France's inoculation campaign got off to a slow start, hampered in part by red tape and President Emmanuel Macron's decision to tread warily in one of the world's most vaccine-sceptical countries. France has fallen behind neighbours such as Britain and Germany, and the president is now demanding the vaccination programme be expedited